Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: A retrospective comparative study

Hepato-Gastroenterology

Volumn 55, Issue 86-87, 2008, Pages 1895-1898

  Wang, Lin Bo ^a   Shen, Jian Guo ^a   Xu, Chao Yang ^a   Chen, Wen Jun ^a   Song, Xiang Yang ^a   Yuan, Xiao Ming ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Curative resection rate; Gastric cancer; Neoadjuvant chemotherapy

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; LAPAROTOMY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; STOMACH CANCER; SURVIVAL TIME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 57049086969     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Green D, Ponce de Leon S, Leon-Rodriguez E, Sosa-Sanchez R: Adenocarcinoma of the stomach: univariate and multivariate analysis of factors associated with survival. Am J Clin Oncol 2002; 25:84-89.
2. Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J: Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer 2000; 36:390-396.
3. Gonzalez RJ, Mansfield PF: Adjuvant and neoadjuvant therapy for gastric cancer. Surg Clin North Am 2005; 85:1033-1051.
4. Lim L, Michael M, Mann GB, Leong T: Adjuvant therapy in gastric cancer. J Clin Oncol 2005; 23:6220-6232.
5. Kelsen DP: Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol 1996; 23:379-389.
6. Extra JM, Marty M, Brienza S, Misset JL: Pharmacokinetics and safety profile of oxaliplatin. Semin Oncol 1998; 25:13-22.
7. Louvet C, Andre T, Tigaud JM, Gamelin E, Douillard JY, Brunet R, Francois E, Jacob JH, Levoir D, Taamma A, Rougier P, Cvitkovic E, de Gramont A: Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol 2002; 20:4543-4548.
8. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. WHO offset publication No. 48. Geneva: World Health Organization, 1979.
9. Schuhmacher CP, Fink U, Becker K, Busch R, Dittler HJ, Mueller J, Siewert JR: Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up. Cancer 2001; 91:918-927.
10. Gallardo-Rincon D, Onate-Ocana LF, Calderillo-Ruiz G: Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study. Ann Surg Oncol 2000; 7:45-50.
11. Mauer AM, Kraut EH, Krauss SA, Ansari RH, Kasza K, Szeto L, Vokes EE: Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol 2005; 16:1320-1325.
12. Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A: Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002; 20: 1996-2004.
13. Sastre J, Garcia-Saenz JA, Diaz-Rubio E: Chemotherapy for gastric cancer. World J Gastroenterol 2006; 12:204-213.
14. Ott K, Sendler A, Becker K, Dittler HJ, Helmberger H, Busch R, Kollmannsberger C, Siewert JR, Fink U: Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Gastric Cancer 2003; 6:159-167.
15. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355:11-20.
16. Kienle P, Buhl K, Kuntz C, Dux M, Hartmann C, Axel B, Herfarth C, Lehnert T: Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia. Digestion 2002; 66:230-236.